• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

布托啡诺与纳布啡减轻开放性脊柱手术患者导管相关膀胱不适及苏醒期躁动的比较:一项随机临床试验

Comparison between butorphanol and nalbuphine for alleviation of catheter-related bladder discomfort and emergence agitation in patients undergoing open spinal surgery: a randomized clinical trial.

作者信息

Wang Weilian, Zhang Chang, Zhou Qian, Dan Jiapeng, Zhang Kun, Zheng Ting

机构信息

Department of Anesthesiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian, China.

Department of Anesthesiology, Jingzhou Central Hospital, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, Hubei, China.

出版信息

Ann Med. 2025 Dec;57(1):2534853. doi: 10.1080/07853890.2025.2534853. Epub 2025 Jul 25.

DOI:10.1080/07853890.2025.2534853
PMID:40711580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12302433/
Abstract

INTRODUCTION

Opioid receptor agonist/antagonists have positive effects in the management of catheter-related bladder discomfort (CRBD). Whether the differences in κ receptor affinity will have different effects is still unknown. This study aims to compare the efficacy of opioid agents with varying κ receptor affinity profiles in alleviating CRBD and emergence agitation (EA).

PATIENTS AND METHODS

A total of 120 patients undergoing open spinal surgery were randomly assigned into three groups: saline group, butorphanol group, and nalbuphine group. All drugs were injected intravenously 30 min before the end of surgery. The primary outcomes were the incidence of moderate to severe CRBD and EA at 5 min after tracheal extubation. Secondary outcomes included the severity of CRBD, numerical rating scales (NRS), Richmond agitation-sedation scale (RASS) at five time points after tracheal extubation, the need for rescue analgesia and the incidence of adverse events were also recorded.

RESULTS

The incidence of moderate to severe CRBD was significantly lower in group B compared to group C ( < 0.001) at all the time points. Group B had significantly fewer patients with severe CRBD and lower NRS scores than both groups C and N ( < 0.001) at T1 and T2. Group B had lower RASS scores than groups N and C at T1, while at T2, T3 and T4, groups B and N continued to exhibit significantly lower NRS scores compared to group C ( < 0.001). The requirement for rescue analgesia decreased sequentially from group C to group N and then to group B ( < 0.001). The incidence of EA was significantly lower in groups B and N than in group C ( < 0.001).

CONCLUSIONS

Opioid receptor agonist/antagonists demonstrate efficacy in preventing CRBD and EA without significant adverse events. Butorphanol exhibits superior efficacy to nalbuphine in the early postoperative period.

摘要

引言

阿片受体激动剂/拮抗剂在导管相关性膀胱不适(CRBD)的管理中具有积极作用。κ受体亲和力的差异是否会产生不同影响尚不清楚。本研究旨在比较具有不同κ受体亲和力谱的阿片类药物在缓解CRBD和苏醒期躁动(EA)方面的疗效。

患者与方法

总共120例行开放性脊柱手术的患者被随机分为三组:生理盐水组、布托啡诺组和纳布啡组。所有药物均在手术结束前30分钟静脉注射。主要结局是气管拔管后5分钟时中重度CRBD和EA的发生率。次要结局包括CRBD的严重程度、数字评分量表(NRS)、气管拔管后五个时间点的里士满躁动镇静量表(RASS),还记录了补救镇痛的需求和不良事件的发生率。

结果

在所有时间点,B组中重度CRBD的发生率均显著低于C组(<0.001)。在T1和T2时,B组严重CRBD患者明显少于C组和N组,且NRS评分更低(<0.001)。在T1时,B组的RASS评分低于N组和C组,而在T2、T3和T4时,B组和N组的NRS评分继续显著低于C组(<0.001)。补救镇痛的需求从C组到N组再到B组依次降低(<0.001)。B组和N组的EA发生率显著低于C组(<0.001)。

结论

阿片受体激动剂/拮抗剂在预防CRBD和EA方面显示出疗效,且无明显不良事件。在术后早期,布托啡诺的疗效优于纳布啡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e11f/12302433/c7a77a388882/IANN_A_2534853_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e11f/12302433/77bfd21a9af9/IANN_A_2534853_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e11f/12302433/7bb971a94e38/IANN_A_2534853_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e11f/12302433/c7a77a388882/IANN_A_2534853_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e11f/12302433/77bfd21a9af9/IANN_A_2534853_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e11f/12302433/7bb971a94e38/IANN_A_2534853_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e11f/12302433/c7a77a388882/IANN_A_2534853_F0003_C.jpg

相似文献

1
Comparison between butorphanol and nalbuphine for alleviation of catheter-related bladder discomfort and emergence agitation in patients undergoing open spinal surgery: a randomized clinical trial.布托啡诺与纳布啡减轻开放性脊柱手术患者导管相关膀胱不适及苏醒期躁动的比较:一项随机临床试验
Ann Med. 2025 Dec;57(1):2534853. doi: 10.1080/07853890.2025.2534853. Epub 2025 Jul 25.
2
Dose-Response Analysis of Nalbuphine for Alleviating Catheter-Related Bladder Discomfort After Ureteroscopic Lithotripsy in Men: A Retrospective Study.纳布啡缓解男性输尿管镜碎石术后导尿管相关膀胱不适的剂量反应分析:一项回顾性研究
Drug Des Devel Ther. 2025 Jun 19;19:5283-5292. doi: 10.2147/DDDT.S511613. eCollection 2025.
3
Effect of intravenous lidocaine on catheter‑related bladder discomfort, postoperative pain and opioid requirement in complex fusion lumbar spinal surgery: a randomized, double blind, controlled trial.静脉注射利多卡因对复杂融合腰椎脊柱手术中导管相关膀胱不适、术后疼痛和阿片类药物需求的影响:一项随机、双盲、对照试验。
BMC Anesthesiol. 2024 Nov 11;24(1):405. doi: 10.1186/s12871-024-02789-y.
4
Nalbuphine for postoperative pain treatment in children.纳布啡用于儿童术后疼痛治疗
Cochrane Database Syst Rev. 2014 Jul 31;2014(7):CD009583. doi: 10.1002/14651858.CD009583.pub2.
5
Esketamine for Preventing Catheter-Related Bladder Discomfort After Ureteroscopic Lithotripsy: A Randomized Controlled Trial.艾氯胺酮预防输尿管镜碎石术后导尿管相关膀胱不适的随机对照试验
BMC Anesthesiol. 2025 Jul 29;25(1):361. doi: 10.1186/s12871-025-03236-2.
6
Safety and efficacy of low-dose esketamine weakly opioidized anesthesia in elderly patients with lumbar spinal stenosis undergoing surgery: a prospective, double-blind randomized controlled trial.低剂量艾司氯胺酮联合弱阿片类药物麻醉在老年腰椎管狭窄症手术患者中的安全性和有效性:一项前瞻性、双盲随机对照试验。
BMC Anesthesiol. 2025 Feb 5;25(1):57. doi: 10.1186/s12871-025-02908-3.
7
Is the Use of a Buprenorphine Transdermal Patch More Effective Than Oral Medications for Postoperative Analgesia After Arthroscopic Rotator Cuff Repair? A Randomized Clinical Trial.对于关节镜下肩袖修补术后的镇痛,丁丙诺啡透皮贴剂的使用是否比口服药物更有效?一项随机临床试验。
Clin Orthop Relat Res. 2025 May 1;483(5):857-865. doi: 10.1097/CORR.0000000000003303. Epub 2024 Nov 5.
8
Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.用于癌症患者和接受姑息治疗患者的阿片类药物引起的肠道功能障碍的μ-阿片受体拮抗剂。
Cochrane Database Syst Rev. 2018 Jun 5;6(6):CD006332. doi: 10.1002/14651858.CD006332.pub3.
9
Use of disposable painless silicone urethral catheter during urological surgery for male patients: a randomized controlled study.一次性无痛硅胶导尿管在男性患者泌尿外科手术中的应用:一项随机对照研究。
World J Urol. 2025 Mar 31;43(1):199. doi: 10.1007/s00345-025-05506-7.
10
Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery in adults.成人围手术期持续静脉输注利多卡因用于术后疼痛及恢复
Cochrane Database Syst Rev. 2018 Jun 4;6(6):CD009642. doi: 10.1002/14651858.CD009642.pub3.

引用本文的文献

1
Regarding: 'comparison between butorphanol and nalbuphine for alleviation of catheter-related bladder discomfort and emergence agitation in patients undergoing open spinal surgery: a randomized clinical trial'.关于:“布托啡诺与纳布啡减轻开放性脊柱手术患者导尿管相关膀胱不适及苏醒期躁动的比较:一项随机临床试验”
Ann Med. 2025 Dec;57(1):2552938. doi: 10.1080/07853890.2025.2552938. Epub 2025 Sep 1.

本文引用的文献

1
HSK21542 in patients with postoperative pain: two phase 3, multicentre, double-blind, randomized, controlled trials.HSK21542用于术后疼痛患者:两项3期、多中心、双盲、随机对照试验。
Nat Commun. 2025 May 24;16(1):4830. doi: 10.1038/s41467-025-60013-y.
2
Population pharmacokinetic modeling and exposure-response analysis of anrikefon: insights and implications in clinical analgesia.安瑞克芬的群体药代动力学建模与暴露-反应分析:临床镇痛中的见解与启示
Expert Rev Clin Pharmacol. 2025 Jan-Feb;18(1-2):77-88. doi: 10.1080/17512433.2025.2449983. Epub 2025 Jan 23.
3
Effect of intravenous lidocaine on catheter‑related bladder discomfort, postoperative pain and opioid requirement in complex fusion lumbar spinal surgery: a randomized, double blind, controlled trial.
静脉注射利多卡因对复杂融合腰椎脊柱手术中导管相关膀胱不适、术后疼痛和阿片类药物需求的影响:一项随机、双盲、对照试验。
BMC Anesthesiol. 2024 Nov 11;24(1):405. doi: 10.1186/s12871-024-02789-y.
4
Machine learning-based prediction of the risk of moderate-to-severe catheter-related bladder discomfort in general anaesthesia patients: a prospective cohort study.基于机器学习的全麻患者中中重度导管相关膀胱不适风险预测:一项前瞻性队列研究。
BMC Anesthesiol. 2024 Sep 19;24(1):334. doi: 10.1186/s12871-024-02720-5.
5
Comparison between the Efficacy of Sacral Erector Spina Plane Block and Pudendal Block on Catheter-Related Bladder Discomfort: A Prospective Randomized Study.骶棘肌平面阻滞与阴部神经阻滞对导管相关性膀胱不适疗效的比较:一项前瞻性随机研究。
J Clin Med. 2024 Jun 20;13(12):3617. doi: 10.3390/jcm13123617.
6
Impact of butorphanol versus sufentanil on postoperative cognition and inflammation in elderly: a pilot study.布托啡诺与舒芬太尼对老年患者术后认知及炎症的影响:一项初步研究。
Front Aging Neurosci. 2024 Jun 7;16:1395725. doi: 10.3389/fnagi.2024.1395725. eCollection 2024.
7
Effectiveness of Butorphanol in alleviating intra- and post-operative visceral pain following microwave ablation for hepatic tumor: a dual-central, randomized, controlled trial.布托啡诺缓解肝肿瘤微波消融术中及术后内脏痛的有效性:一项双中心、随机、对照试验。
Sci Rep. 2024 Mar 19;14(1):6639. doi: 10.1038/s41598-024-56876-8.
8
Comparison of postoperative analgesia and side effects in pediatric laparoscopic surgery with morphine and nalbuphine.小儿腹腔镜手术中吗啡与纳布啡术后镇痛及副作用的比较
iScience. 2024 Feb 20;27(3):109287. doi: 10.1016/j.isci.2024.109287. eCollection 2024 Mar 15.
9
Application of Butorphanol versus Sufentanil in Multimode Analgesia via Patient Controlled Intravenous Analgesia After Hepatobiliary Surgery: A Retrospective Cohort Study.布托啡诺与舒芬太尼用于肝胆手术后患者自控静脉镇痛多模式镇痛的效果比较:一项回顾性队列研究。
Drug Des Devel Ther. 2023 Dec 20;17:3757-3766. doi: 10.2147/DDDT.S433136. eCollection 2023.
10
Nalbuphine May Be Superior to Sufentanil in Relieving Postcesarean Uterine Contraction Pain in Multiparas: A Retrospective Cohort Study.纳布啡在缓解多产妇剖宫产术后子宫收缩痛方面可能优于舒芬太尼:一项回顾性队列研究。
Drug Des Devel Ther. 2023 May 8;17:1405-1415. doi: 10.2147/DDDT.S394664. eCollection 2023.